China National Accord Medicines financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥1.58B ¥1.64B ¥5.71B ¥6.88B ¥8.76B ¥11.00B ¥13.06B ¥15.15B ¥18.01B ¥21.20B ¥23.95B ¥37.82B ¥41.25B ¥41.26B ¥43.12B ¥52.05B ¥59.65B ¥68.36B ¥73.44B ¥75.48B ¥0.00M
GM % Gross Margin %
23.68% 22.81% 10.69% 10.21% 8.87% 8.63% 8.65% 8.68% 8.78% 8.16% 8.06% 11.53% 11.13% 10.76% 11.78% 11.01% 11.78% 11.68% 12.09% 11.93% 0.00%
OM Operating Margin
1.58% 2.45% 2.34% 2.40% 2.59% 2.45% 2.89% 3.26% 3.86% 3.64% 3.68% 3.53% 3.46% 3.11% 3.32% 3.29% 3.25% 2.97% 3.12% 3.11% 0.00%
EPS Earnings Per Share
¥0.65 ¥0.83 ¥1.19 ¥1.35 ¥1.37 ¥1.52 ¥1.51 ¥1.86 ¥2.11 ¥2.21 ¥2.46 ¥2.56 ¥2.75 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.10 ¥0.00 ¥0.14 ¥0.15 ¥0.23 ¥0.25 ¥0.23 ¥0.31 ¥0.31 ¥0.62 ¥0.46 ¥0.62 ¥0.68 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 12.05% 0 10.37% 10.95% 15.13% 16.56% 12.37% 14.69% 14.03% 25.20% 0 24.22% 24.73% 0
Sha. Shares
288.15m 288.15m 288.15m 288.15m 288.15m 288.15m 288.15m 288.15m 288.15m 288.15m 362.63m 362.63m 362.63m 428.13m 428.13m 428.13m 428.13m 428.13m 428.13m 0m 556.57m
OCF Operating Cash Flow
¥122.03M ¥148.28M ¥181.73M ¥87.70M ¥251.67M ¥273.86M ¥428.16M ¥230.10M ¥323.96M ¥465.03M ¥-796.70M ¥1.46B ¥1.47B ¥1.29B ¥1.32B ¥2.00B ¥1.50B ¥1.66B ¥2.56B ¥2.94B ¥0.00M
FCF Free Cash Flow
¥105.48M ¥97.66M ¥63.51M ¥16.29M ¥177.09M ¥170.19M ¥250.17M ¥31.13M ¥132.77M ¥319.36M ¥-1138.00M ¥1.16B ¥1.23B ¥1.08B ¥1.07B ¥1.76B ¥1.21B ¥1.28B ¥2.24B ¥2.61B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.37 ¥0.34 ¥0.22 ¥0.06 ¥0.57 ¥0.59 ¥0.87 ¥0.11 ¥0.45 ¥1.09 ¥-3.31 ¥2.74 ¥2.85 ¥2.52 ¥2.49 ¥4.10 ¥2.82 ¥2.31 ¥4.02 ¥4.70 ¥0.00